KAYNAKLAR

  1. Zipes DP, Duffin EG: Cardiac pacemakers, In E Braunwald (ed) Heart Disaese, A textbook of cardiovascular medicine, Philedelphia, WB Saunders Company, 1984;744
  2. Barold SS, Falkoff MD, Ong LS et al: Function and electrocardiography of DVI pacing systems, In SS Barold (ed): Modern cardiac pacing, New York: Futura Publishing, 1985;625
  3. Barold SS, Falkoff MD, Ong LS et al: Function and electrocardiography of DDD pacing systems, In SS Barold (ed): Modern cardiac pacing, New York: Futura Publishing, 1985;645
  4. Floro J, Catellanet M, Florio J et al: DDI: A new mode for cardiac pacing. Clin. Prog. Pacing and electrophysiol 1984;2:255
  5. Gregoratos G, Cheitlin MD,Conill A, et al: ACC/AHA Guidelines for implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Executive Summary. A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Comittee on Pacemaker Implantation). Circulation, 1998; 97: 1325-35
  6. Hidman MC, Wagner GS, JaRo M, et al: The clinical significance of bundle branch block complicating acute myocardial infarction: indications for temporary and permanent pacemaker insertion .Circulation 1978;58:689-99
  7. Recommendations for pacemaker prescription for symptomatic bradycardia: report of working party of the British Pacing and Electrophysiology Group Br Heart J 1991;66:185-91
  8. Andersen HR, Thuesen L, Bagger JP, Vesterlund T, Thomsen PE: Prospective randomised trial of atrial versus ventricular pacing in sick-sinus syndrome.Lancet 1994;344:1523-8
  9. Gregators G, Cheitlin MD, Conill Ave ark: ACC/AHA Guidelines for implantation of cardiac pacemakers and antiarrhythmia devices .A report of the American College of Cardiology / American Heart Association Task force on practice guidelines (Committee on pacemaker implantation) JACC 1998;31:1175-209
  10. Fisher JD, Johnston DR, Furman S, Mercando AD, Kim SG: Long - term efficacy of antitachycardia pacing for supraventricular and ventricular tachycardias .Am J Cardiol 1987;60:1311-6
  11. Eldar M, Griffin JC, Van Hare GF, et al: Combined use of beta-adrenergic blocking agents and long-term cardiac pacing for patients with the long QT syndrome. J Am Coll Cardiol 1992;20:830-7
  12. Sutton R, Petersen M, Brignole M, Raviele A, Mennozi C, Giani P: Proposed classification for tilt-induced vasovagal syncope. Eur J Cardiac Pacing Electrophysiol 1992;2:180-3
  13. Connolly SJ, Sheldon RS, Gent M, Roberts RS, VPS Investigators. A randomized trial of cardiac pacing for recurrent fainting: the Vasogal Pacemaker Study (VPS). Presented at the North American Society of Pacing and Electrophysiology 18th Annual Scientific Session; May 1997; New Orleans La.
  14. Petersen ME, Chamberlain-Webber R, Fitzpatrick AP, Ingram A, Williams T, Sutton R: Permanent pacing for cardioinhibitory malignant vasovagal syndrome. Br Heart J 1994;71:274-81
  15. Pinsky WW, Gillette PC, Garson A Jr, McNamara DG: Diagnosis, management, and long-term results of patients witht congenital complete atrioventricular block. Pediatrics 1982;69:728-33
  16. Michaelsson M, Eagle MA: Congenital complete heart block: an international study of the natural history. Cardiovasc Clin 1972;4:85-101
  17. Moss AJ, Liu JE, Gottlieb S, Locati EH, Schwartz PJ, Robinson JL: Efficacy of permanent pacing in the management of high - risk patients with long QT syndrome.Circulation 1991;84:1524-9
  18. Fananapazir L, Epstein ND, Curiel RV, Panza JA, Tripodi D, McAreavey D: Long-term results of dual- chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy: evidence for progressive symptomatic and hemodynamic improvement and reduction of of left ventricular hypertrophy. Circulation 1994;90:2731-42
  19. Nishimura RA, Symanski JD, Hurrell DG, Trusty JM, Hayes DL, Tajik AJ: Dual- chamber pacing for cardiomyopathies: a 1996 clinical perspective. Mayo Clin Proc 1996;71:1077-87
  20. Nishimura RA, Hayes DL, Holmes Dr, Tajik AJ: Mechanism of hemodynamic improvement by dual-chamber pacing for severe left ventricular dysfunction : an acute Doppler and catheterization hemodynamic study.J Am Coll Cardiol 1995;25:281-8
  21. Hochleitner M, Hornagl H, Fridrich L, Gschnitzer F: Long-term efficacy of physiologic dual-chamber pacing in the treatment of end -stage idiopathic dilated cardiomypathy. Am J Cardiol 1992;70:1320-5
  22. Auricchio A.Sommariva L, Salo RW, Scafuri A, Chiariello L: Improvement of cardiac function in patients with severe congestive heart failure and coronary artery disease by dual chamber pacing with shortened AV delay. Pacing Clin Electrophysiol 1993;16:2034-43
  23. Gasparini M, Gulizia M, Mantica M ve ark: In Sync Italien registry. Does biventricular pacing impact on patients, hospitalization? Pacing Clin Electrophysiol 2001:24:643
  24. Lau CP, Yu CM, Chau ve ark: Reversal of left ventricular remodeling by synchronous biventricular pacing in heart failure. Pacing Clin Electrophysiol 2000;23:1722-5
  25. Barbea S, Smith ML , Kowal RC ve ark: Biventricular pacing decreases sympathetic nerve activity compared with intrinsic conduction in patients with heart failure and conduction delay Pacing Clin Electrophysiol 2001:24:731
  26. Gras D, Mabo P, tang T ve ark: Multisite Pacing as a supplemental treatment of congestive heart failure.Preliminary results of the Medtronic Inc. In Sync Study. Pacing Clin Electrophysiol: 1998;21:2249-55
  27. Myerburg RJ, Castellanos A: Cardiac arrest and sudden cardiac death. In Braunwald E (eds): Heart Disease. A. Textbook of Cardiovascular Medicine.4th edition. Philedelphia, WB Saunders Comp. 1992;756-89
  28. Mitrani RD, Klein RS, Randon DP, Zipes DP, Miles WM: Current trends in the implantable cardioverter defibrillator. In Zipes DP, Jalife J (Eds): Cardiac Electrophysiology: From Cell to Bedside 2nd editon. WB Saunders Company. 1995;1393-403
  29. Bardy GH, Yee R, jung F, for Active Can Investigators. Multicenter experience with a pectoral implantable cardioverter defibrillator. J Am Coll Cardiol 1996;28:400-410
  30. Mohamed Y: Surgical technigues for implantation of the implantable cardioverter defibrillator. In Zipes DP, Jalife J (Eds): Cardiac Electrophysiology: From Cell to Bedside. 2nd edition. WB Saunders Company. 1995;1403-12
  31. Saksena S, for the PCD Investigators. Clinical outcome of patients with malignant ventricular tachyarrhythmias and a multiprogrammable implantable cardioverter-defibrillator implanted with or without thoracotomy: an international multicenter study. J Am Coll Cardiol 1994;23: 1521-30
  32. The AVID investigators. A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near fatal ventricular arrhythmias. N Engl J Med 1997;337:1576-83
  33. Groh WJ, Silka MJ, Oliver RP, Halperin BD, McAnulty JH, Kron J: Use of implantable cardioverter-defibrillators in the congenital long QT syndrome. Am J Cardiol 1996;78:703-6
  34. Breithard G, Witcher T, Haverkamp W, et al: Implantable cardioverter defibrillator therapy in patients with arrhythmogenic right ventricular cardiomyopathy, long QT syndrome, or no structural heart disease. Am Heart J 1994; 127:1158-8
  35. Garson AJ, Dick MI, Fournier A, et al: The long QT Syndrome in children: an International study of 287 patients. Circulation 1993;87:1866-72
  36. The Cardiac Arrhythmia Supression Trial (CAST) Investigators. Preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia supression after myocardial infarction. N Engl J Med 1989; 321:406-12
  37. Carius JA, Connoly SJ, Roberts R et al: Randomized trial of outcome after myocardial infarction in patients with frequent or repetetive ventricular premature depolarization. CAMIAT. Lancet 1997;349:675
  38. Julian DG, Camm AJ, Frangin G et al: Randomized trial of effect of Amiodarone on mortality in patient with left ventricular dysfuction after recent myocardial infarction. EMIAT. Lancet 1997;349:667
  39. Burkart F, Pfistere M, Kiowski W et al: Effects of antiarrhythmic therapy on mortality in survivals of myocardial infarction with asymptomatic complex ventricular arrhythmias. Basel Antiarrhythmic Study of Infarct Survival (BASIS). J. Am Coll Cardiol 1990;16:1711
  40. Waldo AL, Camm AJ, de Ruyter H et al: SWORD. Survival with oral d-sotalol in patients with left ventricular dysfunction after recent and remote myocardial infarction. Lancet 1996;348:7
  41. The CASCADE Investigators: Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (CASCADE). Am J Cardiol 1993;329:445
  42. Mason JW: A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. N Engl J Med 1993;329:452-8
  43. Doval HC, Nul DR, Grancelli HO et al: for Grupo de Estudio de Sobrevida en al Insuficiencia Cardiaca en Argentina (GESICA). Randomized trial of- low- dose amiodarone in severe congestive heart failure. Lancet 1994; 334:493
  44. Singh SN, Flecher RD, Fisher SG et al: CHF-STAT. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. N Engl J Med 1995; 333:77
  45. Moss AJ, Hall WJ, Cannom DS et al for MADIT Investigators: Impoved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. New Engl J Med 1996;335:1933-40
  46. AVID Investigators: A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near -fatal ventricular arrhythmias. N Engl J Med 1997;337:1576
  47. Canadian Implantable Defibrillator Study (CIDS). Meeting Highligts. 47th Annual scientific session of the American College of Cardiology. Circulation 1998;97: 2377
  48. Ferguson JJ: The Cardiac Arrest Study Hamburg (CASH) . Meeting Highlights 47. Annual scientific Sessions of the American College of Cardiology. Circulation 1998;31:1175
  49. Bigger JT for CABG - PATCH Investigators. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary artery bypass graft surgery. N Engl J Med 1997; 337: 1569-75
  50. Sheldon R, Connolly S, Krahn A ve ark: Identification of patients most likely to benefit from implantable cardioverter-defibrillator therapy. The Canadian Ýmplantable defibrillator study. Circulation 2000;101:1664
    51.
  51. Moss AJ: Implantable cardioverter defibrillator therapy. The sickest patients benefit the most. Circulation: 2000;101:1638-40
  52. Winters SL, Packer DL, Marchlinski FE and et: Consensus statement on indications, guidelines, for use and recommendations for follow-up of implantable cardioverter defibrillators Pacing Clin Electrophysiol: 2001;24:262-9
  53. Klein LS, Shih HT, Hackett FK, Zipes DP, Miles WM: Radiofrequency catheter ablation of ventricular tachycardia in patients without structural heart disease. Circulation, 1992;85:1666-74
  54. Wen MS, Yeh SJ, Wang CC, Lin FC, Chen IC, Wu D. Radiofrequency ablation therapy in idiopathic left ventricular tachycardia with no obvious structural heart disease. Circulation 1994;89:1690-6
  55. Stricberger SA, Man KC, Daoud EG, Goyal R, Brinkman K, Hasse C, Bogun F, Knight BP, Weiss R, Bahu M, Morady F: A prospective evaluation of catheter ablation of ventricular tachycardia as adjuvant therapy in patients with coronary artery disease and an implantable cardioverter - defibrillator. Circulation 1997;96:1525 -31
  56. Fogoros RN, Elson JJ, Bonnet CA, Fiedler SB, Burkholder JA: Efficacy of the automatic implantable cardioverter-defibrillator in prolonging survival in patients with severe underlying cardiac disease. J Am Coll Cardiol 1990;16:381-6
  57. Borggrefe M, Chen X, Martinez - Rubio A, et al: The role of implantable cardioverter defibrillators in dilated cardiomyopathy. Am Heart J 1994;127:1145-50
  58. Nisam S, Kaye SA, Mover MM, Hull M, AICD automatic cardioverter defibrillator clinical update:14 years experience in over 34,000 patients. Pacing Clin Electrophysiol 1995;18:142

Kaminer SJ, Pickoff AS, Dunnigan A, Sterba R, Wollf GS, Cardiomyopathy and the use of implanted cardio-defibrillators in children. Pacing Clin Electrophysiol 1990;13:593-7